Semiquinone Radical‐Engineered Nanoparticles for Hypoxia‐Adaptive and InflammationControlled Microwave‐Immunotherapy of Liver Tumor
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.202503568 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Meizhen Zhou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interventional Ultrasound, Fifth Medical Center of Chinese PLA General Hospital, Beijing, 100071, China. Hauptthemen laut MEDLINE: Microwaves, Nanoparticles, Immunotherapy, Liver Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Reactive Oxygen Species (ROS) exhibit a paradoxical dual role in tumor therapy. Tumor hypoxia restricts therapeutic ROS generation, while excessive secondary ROS post‐ablation suppresses T‐cell function yet promotes M1 macrophage polarization. Semiquinone radical‐doped reduced polydopamine nanoparticles (PDA red ) loaded is developed with resiquimod (R848) (PDA red @R848) via π–π stacking. Reduction enriches the nanoparticles with semiquinone radicals, enhancing dielectric properties and dipole polarization under electromagnetic effects. This nanoparticle enables the specific hydrogen radicals (H•)/ROS generation in oxygen‐heterogeneous tumor under microwave irradiation. In microwave dynamics therapy (MDT) phase, PDA red converts protons (H⁺) to H• under microwave irradiation in hypoxic regions, targeting cytochrome c and inducing tumor cell apoptosis and immunogenic cell death; PDA red establishes an internal electric field under microwave, facilitating electron–hole separation to produce ROS and trigger ferroptosis in normoxic regions. In post‐MDT phase, PDA red ’s intrinsic polyphenols scavenge excess secondary ROS produced by damaged cells, alleviating immunosuppression. Compared with blank control, PDA red @R848 increased CD4⁺/CD8⁺ T‐cell infiltration (6.4‐fold) and M1 macrophage polarization (2.5‐fold M1/M2 ratio elevation). Pro‐inflammatory cytokines are significantly reduced, and tumor volume is suppressed by 94.8%. This study proposes an innovative dual‐action mechanism coordinating oxygen‐adapted radical generation with secondary ROS clearance to reprogram redox/immune homeostasis for effective liver tumor eradication.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Interventional Ultrasound, Fifth Medical Center of Chinese PLA General Hospital, Beijing, 100071, China.
- Key Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University, Chongqing, 400044, China.
ORCID-Profile: Ping Liang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhou, M., Zhu, J., Zhang, D., Dou, J., Chen, W., Zhang, Y., Gao, X., Zhang, J., Liang, P., & Yu, J. (2026). Semiquinone Radical‐Engineered Nanoparticles for Hypoxia‐Adaptive and InflammationControlled Microwave‐Immunotherapy of Liver Tumor. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202503568
Vancouver
Zhou M, Zhu J, Zhang D, Dou J, Chen W, Zhang Y, et al. Semiquinone Radical‐Engineered Nanoparticles for Hypoxia‐Adaptive and InflammationControlled Microwave‐Immunotherapy of Liver Tumor. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202503568
BibTeX
@article{Zhou2026,
author = {Zhou, Meizhen and Zhu, Jing and Zhang, Dongyun and Dou, Jianping and Chen, Wenqi and Zhang, Yi and Gao, Xiaopeng and Zhang, Jixi and Liang, Ping and Yu, Jie},
title = {Semiquinone Radical‐Engineered Nanoparticles for Hypoxia‐Adaptive and InflammationControlled Microwave‐Immunotherapy of Liver Tumor},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.202503568}
}
EUVIMED